Clinical Tests

We are pleased to announce a very Special Prenatal Package which includes our Non Invasive Prenatal Paternity Test, Non Invasive Prenatal Screening Test for Down’s Syndrome and many other Chromosomal Disorders.

Do you want to take better control of your health and that of your loved ones? EasyDNA offer you an innovative DNA test that can identify your risks towards developing certain disease. Your opportunity to be proactive and manage your own health and wellbeing!

Postnatal Peace is proud to be able to offer Nova™.

Nova™ is a newborn screening test that determines a baby’s risk for 50 inherited disorders, as well as providing personalised genetic information on the metabolism of 20 drugs. Nova™ utilises Next Generation sequencing technology, coupled with the leading genetics bioinformatics software. Postnatal peace is able to offer the most comprehensive and accurate newborn screening test that is over 99.99% accurate.

Pharmacogenomics (PGx) is the analysis of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic make-up. PGx is able to provide information about a patient’s genetic likelihood to respond to a given medication or risk of an adverse drug response (ADR).

Our Inherited Disease Panel tests for over 300 genes with over 700 unique inherited diseases, including neuromuscular, cardiovascular, developmental, and metabolic diseases and is often used to show a genetic compatibility between a couple or exclude it.

This specialized panel includes analysis of the BRCA1 and BRCA2 genes. BRCA1 and BRCA2 gene mutations can increase your risk of breast and ovarian cancer and are implicated in a high number of breast cancer cases.

Our Inherited Cancer Panel specifically looks for inherited gene mutations in over 130 different genes associated with a wide range of hereditary cancers (including BRCA1, BRCA2 & PALB2). This screening test can be used to identify gene mutations responsible for hereditary cancers and to clarify the genetic risk for individuals with a family history of these hereditary cancers. It is a powerful tool that can help you reduce your risks or undertake measures that will help you detect hereditary cancers as early as possible.